HESTERBIOPharmaceuticals
Hester Biosciences Ltd — PE Ratio & Valuation Analysis
₹1259.10
-4.49%
Current P/E32.04xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E60.8x47.3% below avg
⚠️
0.8% Premium to Industry
HESTERBIO P/E 32.04x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹32.31 | ₹1600 | 49.5x |
| 2024 | ₹22.20 | ₹2399 | 108.1x |
| 2023 | ₹31.30 | ₹1458 | 46.6x |
| 2022 | ₹46.22 | ₹1792 | 38.8x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Hester Biosciences Ltd Valuation
Hester Biosciences Ltd (HESTERBIO) currently trades at 32.04x earnings. The Pharmaceuticals sector average PE is 31.77x. HESTERBIO commands a premium, reflecting high growth expectations. Historically, HESTERBIO has traded at an average PE of 60.8x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
9.18%
Dividend Yield
0.43%
More on Hester Biosciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.